In order to see if the cGAS-STING pathway is indeed upregulated in ccRCC as has been shown in our experiments, we analyzed the mRNA expression levels of cGAS and STING in a cohort of patients with ccRCC from the TCGA Pan-Cancer cohort. This evidence concerns the gene CGAS and nonpapillary renal cell carcinoma.